Stopping a Drug Safely Takes a Team. Medicare Just Funded One Piece of It

CMS has opened the door to paying for supervised deprescribing. Experts say the harder work is building the support patients need.
Stopping a Drug Safely Takes a Team. Medicare Just Funded One Piece of It
Vitalii Stock/Shutterstock
|Updated:
0:00

A patient can leave a doctor’s office with a new prescription in minutes. However, getting help to stop one that is no longer needed can be much harder, even when it is causing side effects or is no longer effective.

Safely tapering a drug may take months of dose adjustments, symptom monitoring, family support, and coordination among doctors, pharmacists, and therapists. For years, much of that work has been hard to see—harder for physicians to get paid for.

On May 4, the Centers for Medicare and Medicaid Services (CMS) issued new guidance clarifying that physicians and care teams may bill Medicare for supervised deprescribing under existing care management codes. The agency created no new billing codes and raised no payment rates.

Sheramy Tsai
Sheramy Tsai
Author
Sheramy Tsai, BSN, RN, is a seasoned nurse with a decade-long writing career. An alum of Middlebury College and Johns Hopkins, Tsai combines her writing and nursing expertise to deliver impactful content. Living in Vermont, she balances her professional life with sustainable living and raising three children.